| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |